Senomyx Inc (SNMX) Financial Statements (2025 and earlier)
Company Profile
Business Address |
4767 NEXUS CENTRE DRIVE SAN DIEGO, CA 92121 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 8731 - Commercial Physical and Biological Research (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
6/30/2018 MRQ | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments, including: | 15,900 | 12,400 | 22,954 | 26,591 | 30,163 | 36,792 | |||
Cash and cash equivalents | 6,233 | 3,587 | 4,818 | 3,961 | 11,201 | 15,427 | |||
Short-term investments | 9,630 | 8,776 | 18,136 | 22,630 | 18,962 | 21,365 | |||
Other undisclosed cash, cash equivalents, and short-term investments | 37 | 37 | |||||||
Receivables | 7,130 | 5,352 | 3,193 | 2,276 | 2,126 | 2,702 | |||
Inventory, net of allowances, customer advances and progress billings | 1,579 | 2,335 | 2,434 | 2,319 | ✕ | ✕ | |||
Inventory | 1,579 | 2,335 | 2,434 | 2,319 | |||||
Other current assets | 467 | 983 | 660 | 993 | 873 | ✕ | |||
Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 845 | ||
Other undisclosed current assets | (37) | (37) | |||||||
Total current assets: | 25,039 | 21,033 | 29,241 | 32,179 | 33,162 | 40,339 | |||
Noncurrent Assets | |||||||||
Property, plant and equipment | 2,561 | 2,731 | 3,334 | 3,835 | 5,653 | 7,910 | |||
Long-term investments and receivables | 2,147 | 2,799 | 5,031 | ||||||
Long-term investments | 2,147 | 2,799 | 5,031 | ||||||
Total noncurrent assets: | 2,561 | 2,731 | 3,334 | 5,982 | 8,452 | 12,941 | |||
TOTAL ASSETS: | 27,600 | 23,764 | 32,575 | 38,161 | 41,614 | 53,280 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 4,920 | 5,490 | 5,303 | 5,903 | 7,119 | 6,538 | |||
Employee-related liabilities | 3,195 | 3,030 | 4,105 | 3,192 | 5,320 | 4,968 | |||
Accounts payable | 575 | 1,079 | 352 | 1,064 | 663 | 393 | |||
Accrued liabilities | 1,150 | 1,381 | 846 | 1,647 | |||||
Other undisclosed accounts payable and accrued liabilities | 1,136 | 1,177 | |||||||
Deferred revenue and credits | 335 | 14 | 4,070 | 5,489 | 9,445 | 10,763 | |||
Other undisclosed current liabilities | 219 | 219 | 219 | 987 | 987 | 987 | |||
Total current liabilities: | 5,474 | 5,723 | 9,592 | 12,379 | 17,551 | 18,288 | |||
Noncurrent Liabilities | |||||||||
Liabilities, other than long-term debt | 2,229 | 1,886 | 1,886 | 1,072 | 2,246 | 6,138 | |||
Deferred revenue and credits | 2,229 | 1,886 | 1,886 | 1,072 | 2,246 | 6,138 | |||
Total noncurrent liabilities: | 2,229 | 1,886 | 1,886 | 1,072 | 2,246 | 6,138 | |||
Total liabilities: | 7,703 | 7,609 | 11,478 | 13,451 | 19,797 | 24,426 | |||
Equity | |||||||||
Equity, attributable to parent | 18,763 | 14,802 | 19,524 | 23,558 | 19,678 | 25,728 | |||
Common stock | 48 | 45 | 45 | 43 | 41 | 40 | |||
Additional paid in capital | 298,242 | 292,932 | 286,991 | 278,362 | 262,317 | 256,470 | |||
Accumulated other comprehensive income (loss) | (5) | (4) | (27) | (10) | 7 | 7 | |||
Accumulated deficit | (279,522) | (278,171) | (267,485) | (254,837) | (242,687) | (230,789) | |||
Total equity: | 18,763 | 14,802 | 19,524 | 23,558 | 19,678 | 25,728 | |||
Other undisclosed liabilities and equity | 1,134 | 1,353 | 1,573 | 1,152 | 2,139 | 3,126 | |||
TOTAL LIABILITIES AND EQUITY: | 27,600 | 23,764 | 32,575 | 38,161 | 41,614 | 53,280 |
Income Statement (P&L) ($ in thousands)
6/30/2018 TTM | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 29,320 | 23,039 | 24,882 | 27,662 | 29,287 | 31,313 | ||
Revenue, net | 21,531 | 9,242 | 7,044 | 5,835 | 4,630 | 4,332 | ||
Gross profit: | 29,320 | 23,039 | 24,882 | 27,662 | 29,287 | 31,313 | ||
Operating expenses | (30,653) | (33,798) | (37,572) | (39,849) | (41,220) | (40,566) | ||
Operating loss: | (1,333) | (10,759) | (12,690) | (12,187) | (11,933) | (9,253) | ||
Nonoperating income | 70 | 73 | 42 | 37 | 35 | 67 | ||
Loss from continuing operations: | (1,263) | (10,686) | (12,648) | (12,150) | (11,898) | (9,186) | ||
Loss before gain (loss) on sale of properties: | (1,263) | (10,686) | (12,648) | (12,150) | (11,898) | (9,186) | ||
Net loss available to common stockholders, diluted: | (1,263) | (10,686) | (12,648) | (12,150) | (11,898) | (9,186) |
Comprehensive Income ($ in thousands)
6/30/2018 TTM | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (1,263) | (10,686) | (12,648) | (12,150) | (11,898) | (9,186) | ||
Comprehensive loss: | (1,263) | (10,686) | (12,648) | (12,150) | (11,898) | (9,186) | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (1) | 23 | (17) | (17) | (23) | |||
Comprehensive loss, net of tax, attributable to parent: | (1,264) | (10,663) | (12,665) | (12,167) | (11,898) | (9,209) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.